Skip to content
Disclosery

Northpond Ventures, LLC

Follow

13F filer, CIK 1911245, Bethesda, MD

Northpond Ventures, LLC reported $55,268,194 across 4 holdings for the quarter ended 2024-06-30, in a 13F-HR filed 2024-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-089657

Period
2024-06-30
Reported value
$55.3M
Holdings
4
Top 10 weight
100%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TBIOnew+546,897$2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CODEX DNA INCexited-9,844,130-$4.33M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2024

Share positions as resolved from 13F-HR 0001104659-24-089657, largest first. % of portfolio is the value over $55,268,194, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KYTXKYVERNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 3,255,426 shares; 2024Q2: 3,255,426 shares 3,255,426$24.4M44.18%0Timeline
VIGIL NEUROSCIENCE INCVIGIL NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: 4,214,498 shares; 2023Q1: 4,214,498 shares; 2023Q2: 4,214,498 shares; 2023Q3: 4,214,498 shares; 2023Q4: 4,214,498 shares; 2024Q1: 4,214,498 shares; 2024Q2: 4,214,498 shares 4,214,498$16.9M30.5%0
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: 1,935,215 shares; 2023Q1: 1,935,215 shares; 2023Q2: 1,935,215 shares; 2023Q3: 1,935,215 shares; 2023Q4: 1,935,215 shares; 2024Q1: 1,935,215 shares; 2024Q2: 1,935,215 shares 1,935,215$12M21.71%0Timeline
TBIOTELESIS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 546,897 shares 546,897$2M3.61%newTimeline

Sold out in Q2 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CODEX DNA INCCODEX DNA INC9,844,130$4.33Mshares

How Q2 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-089657 base2024-08-14acceptance time not in the bulk data set